EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Genetic and hemostatic characterization of PAI-1 deficiency and isolated hyperfibrinolysis: data from the RBiN study

Bauke Haisma, Thomas Nieuwenstein, Sanna R Rijpma, Annet Simons, Nicole M A Blijlevens, Waander L van Heerde, Saskia E M Schols

Research and Practice in Thrombosis and Haemostasis · 2026

DOI: 10.1016/j.rpth.2026.106928 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Research and Practice in Thrombosis and Haemostasis, 2026. Verfasst von Bauke Haisma und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology, Radboud University Medical Center, Nijmegen, the Netherlands. Hauptthemen laut MEDLINE: Plasminogen Activator Inhibitor 1, Fibrinolysis, Hemostasis, Coagulation Protein Disorders. Die Arbeit nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Plasminogen Activator Inhibitor 1FibrinolysisHemostasisCoagulation Protein DisordersHumansFemaleMaleCross-Sectional StudiesAdultPromoter Regions, GeneticFibrinolysinMiddle AgedChildAdolescentPolymorphism, GeneticGenetic Predisposition to DiseaseHemorrhagic Disorders

Stichwörter der Autor:innen

exomeexome sequencinggenetic polymorphismgenetic promoter regiongenotypeinherited blood coagulation disordersmutationplasminogen activator inhibitor-1 deficiency

Substanzen

Plasminogen Activator Inhibitor 1SERPINE1 protein, humanFibrinolysin

Autor:innen und Institutionen

  • Department of Hematology, Radboud University Medical Center, Nijmegen, the Netherlands.
  • Department of Hematologie, Radboud University Medical Center, Hemophilia Treatment Center Nijmegen-Eindhoven-Maastricht, Nijmegen, the Netherlands.
  • Department of Laboratory Medicine, Laboratory of Hematology, Radboud University Medical Center, Nijmegen, the Netherlands.
  • Department of Human Genetics, Radboud University Medical Center, Nijmegen, the Netherlands.
  • Enzyre BV, Noviotech Campus, Nijmegen, the Netherlands.

Zitieren

APA

Haisma, B., Nieuwenstein, T., Rijpma, S. R., Simons, A., Blijlevens, N. M. A., van Heerde, W. L., & Schols, S. E. M. (2026). Genetic and hemostatic characterization of PAI-1 deficiency and isolated hyperfibrinolysis: data from the RBiN study. Research and Practice in Thrombosis and Haemostasis. https://doi.org/10.1016/j.rpth.2026.106928

Vancouver

Haisma B, Nieuwenstein T, Rijpma SR, Simons A, Blijlevens NMA, van Heerde WL, et al. Genetic and hemostatic characterization of PAI-1 deficiency and isolated hyperfibrinolysis: data from the RBiN study. Research and Practice in Thrombosis and Haemostasis. 2026. doi:10.1016/j.rpth.2026.106928

BibTeX
@article{Haisma2026,
  author = {Haisma, Bauke and Nieuwenstein, Thomas and Rijpma, Sanna R and Simons, Annet and Blijlevens, Nicole M A and van Heerde, Waander L and Schols, Saskia E M},
  title = {Genetic and hemostatic characterization of PAI-1 deficiency and isolated hyperfibrinolysis: data from the RBiN study},
  journal = {Research and Practice in Thrombosis and Haemostasis},
  year = {2026},
  doi = {10.1016/j.rpth.2026.106928}
}
Kostenlos starten →